Oral / Topical Hair Loss Protection Stack (8 Week Cycle)
As men age they sometimes begin to lose hair or experience thinning hair. This can be due to a number of factors. Many younger men who run prohormone cycles worry about hair loss due to DHT conversion. The Oral / Topical Hair Loss Protection Stack is a complete 8 Week Hair Protection Stack perfect for running along your 8 week prohormone cycle. This stack features Minoxidil to support hair growth along with Hairfluence to provide nutritive support to promote stronger and healthier hair and Now Foods Saw Palmetto to block DHT conversion. Purchase this alongside the prohormones for your next cycle.Â
Oral / Topical Hair Loss Protection Stack (8 Week Cycle) Highlights & Benefits
- Complete Hair Loss Protection Stack for Prohormone Cycles
- Run Alongside Your 8 Week Prohormone Cycle
- May Help Prevent Hair Loss
- Helps Support Longer, Healthier and Stronger Hair
Directions
Now Foods Saw Palmetto Directions
Take one softgel daily preferably with a meal.Â
ZHOU Hairfluence Directions
Adults take two (2) capsules once daily or as directed by a healthcare professional. For maximum effect, take daily for at least 30 days.
Kirkland Minoxidil Directions
1. Rinse hands with cold water.
2. Open child resistant cap
3. Dispense vertically onto a cold surface
4. Apply to scalp
5. Close cap and wash hands.
Oral / Topical Hair Loss Protection Stack (8 Week Cycle) Ingredients
Now Foods Saw Palmetto Ingredients
Serving Size: 1 Softgel
Saw Palmetto Berry Extract 320mg
(Serenoa repens) (Standardized to 85-95% Fatty Acids)
Pumpkin Seed Oil (Cucurbita pepo) 80mg
(Cold Pressed)
*Daily Value Not Established
Other Ingredients:Â
Vegetarian Softgel Capsule (modified corn starch, glycerin, carrageenan, water).
ZHOU Hairfluence Ingredients
Kirkland Minoxidil Ingredients
butane, bytylated hydroxytoluene, cetyl alcohol, citric acid, dehydrated alcohol, isobutane, lactic acid, polysorbate 60, propane, purified water, stearyl alcohol.
Warnings & Side Effects
Store in a cool dry place after opening.Â
References
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088. PMID: 12196747.
https://pubmed.ncbi.nlm.nih.gov/12196747/
†We make every effort to ensure that the product images displayed on our website faithfully represent what you will receive. However, we recognize that digital representations can sometimes fall short of capturing every nuance of the product's physical attributes. Differences in color, size, and packaging details might exist. To mitigate this, we advise our valued customers to delve into the product descriptions where the specific features, ingredients, and usage instructions of each product are meticulously outlined. This approach helps bridge the gap between expectation and reality, ensuring you are fully informed about your purchase.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, cure, diagnose, or prevent any disease.